BETAPLUS PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
BETAPLUS PHARMA
NACE 21.100, Manufacture of basic pharmaceutical products and pharmaceutical preparations
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€1.3m
2024 · €1.6m-€371,674
Equity
€22.3m
2024 · €21.1m+€1.3m
Cash
€14,655
2024 · €2,481+€12,173
Balance sheet total
€24.9m
2024 · €23.7m+€1.2m
Largest movements
Assets
- Receivables within one year +€1.2m
up €1.2m (+5.3%), from €22.5m to €23.7m
of which Other amounts receivable: +€1.2m
Equity and liabilities
- Profit (loss) carried forward +€1.3m
up €1.3m (+6.9%), from €18.5m to €19.7m
Income statement
- Financial income -€282,222
down €282,222 (-32.9%), from €857,827 to €575,605
- Purchases and services +€152,407
up €152,407 (+6.0%), from €2.5m to €2.7m
- Gross operating margin -€136,364
down €136,364 (-4.8%), from €2.8m to €2.7m
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
€1.6m
Gross operating margin
-€136,364
Staff costs
+€17,555
Depreciation
-€12,382
Write-downs
+€2,409
Other operating charges
+€334
Financial income
-€282,222
Financial charges
-€10,074
Taxes
+€49,071
Result 2025
€1.3m
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€268,543
Investment
-€256,370
Financing
€0
Cash 2024
€2,481
From operations (derived)
+€268,543
Net result for the year
+€1.3m
Depreciation
+€217,122
Stocks and contracts
-€62,970
Receivables within one year
-€1.2m
Deferred charges and accrued income
+€90,525
Trade debts
+€100,984
Tax, wage and social debts
-€157,337
Investment (derived)
-€256,370
Investment in fixed assets (net)
-€256,370
Cash 2025
€14,655
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €23,652,157 | €24,867,199 | +€1.2m | +5.1% |
| Fixed assets | 21/28 | €795,964 | €835,211 | +€39,248 | +4.9% |
| Intangible fixed assets | 21 | €0 | €24,929 | +€24,929 | |
| Tangible fixed assets | 22/27 | €750,743 | €767,266 | +€16,523 | +2.2% |
| Land and buildings | 22 | €60,043 | €95,937 | +€35,894 | +59.8% |
| Plant, machinery and equipment | 23 | €576,016 | €595,018 | +€19,002 | +3.3% |
| Furniture and vehicles | 24 | €43,815 | €23,651 | -€20,164 | -46.0% |
| Leasing and similar rights | 25 | - | €3,233 | +€3,233 | |
| Assets under construction and advance payments | 27 | €70,869 | €49,426 | -€21,443 | -30.3% |
| Financial fixed assets | 28 | €45,221 | €43,017 | -€2,204 | -4.9% |
| Current assets | 29/58 | €22,856,193 | €24,031,988 | +€1.2m | +5.1% |
| Stocks and contracts in progress | 3 | €257,920 | €320,890 | +€62,970 | +24.4% |
| Stocks | 30/36 | €257,920 | €320,890 | +€62,970 | +24.4% |
| Amounts receivable within one year | 40/41 | €22,487,613 | €23,678,790 | +€1.2m | +5.3% |
| Trade receivables | 40 | €613,860 | €588,367 | -€25,493 | -4.2% |
| Other amounts receivable | 41 | €21,873,753 | €23,090,423 | +€1.2m | +5.6% |
| Cash at bank and in hand | 54/58 | €2,481 | €14,655 | +€12,173 | +490.6% |
| Deferred charges and accrued income | 490/1 | €108,178 | €17,653 | -€90,525 | -83.7% |
| Total equity and liabilities | 10/49 | €23,652,157 | €24,867,199 | +€1.2m | +5.1% |
| Equity | 10/15 | €21,055,948 | €22,327,343 | +€1.3m | +6.0% |
| Contributions | 10/11 | €2,391,000 | €2,391,000 | = | 0.0% |
| Capital | 10 | €2,000,000 | €2,000,000 | = | 0.0% |
| Issued capital | 100 | €2,000,000 | €2,000,000 | = | 0.0% |
| Outside capital | 11 | €391,000 | €391,000 | = | 0.0% |
| Share premium | 1100/10 | €391,000 | €391,000 | = | 0.0% |
| Reserves | 13 | €200,000 | €200,000 | = | 0.0% |
| Non-distributable reserves | 130/1 | €200,000 | €200,000 | = | 0.0% |
| Legal reserve | 130 | €200,000 | €200,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €18,464,948 | €19,736,343 | +€1.3m | +6.9% |
| Provisions and deferred taxes | 16 | €1,561,000 | €1,561,000 | = | 0.0% |
| Provisions for liabilities and charges | 160/5 | €1,561,000 | €1,561,000 | = | 0.0% |
| Environmental obligations | 163 | €1,561,000 | €1,561,000 | = | 0.0% |
| Amounts payable | 17/49 | €1,035,208 | €978,856 | -€56,353 | -5.4% |
| Amounts payable within one year | 42/48 | €1,035,208 | €978,856 | -€56,353 | -5.4% |
| Trade debts | 44 | €679,748 | €780,733 | +€100,984 | +14.9% |
| Suppliers | 440/4 | €679,748 | €780,733 | +€100,984 | +14.9% |
| Taxes, remuneration and social security | 45 | €355,460 | €198,123 | -€157,337 | -44.3% |
| Taxes | 450/3 | €45,881 | - | -€45,881 | |
| Remuneration and social security | 454/9 | €309,579 | €198,123 | -€111,456 | -36.0% |
| Turnover | 70 | €5,396,027 | €5,412,070 | +€16,043 | +0.3% |
| Goods, raw materials, services and sundry goods | 60/61 | €2,549,032 | €2,701,439 | +€152,407 | +6.0% |
| Remuneration, social security and pensions | 62 | €1,242,692 | €1,225,138 | -€17,555 | -1.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €204,740 | €217,122 | +€12,382 | +6.0% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €445 | -€1,964 | -€2,409 | |
| Other operating charges | 640/8 | €15,732 | €15,398 | -€334 | -2.1% |
| Gross operating margin | 9900 | €2,846,995 | €2,710,631 | -€136,364 | -4.8% |
| Operating profit (loss) | 9901 | €1,383,386 | €1,254,938 | -€128,449 | -9.3% |
| Financial income | 75/76B | €857,827 | €575,605 | -€282,222 | -32.9% |
| Recurring financial income | 75 | €857,827 | €575,605 | -€282,222 | -32.9% |
| Financial charges | 65/66B | €90,466 | €100,539 | +€10,074 | +11.1% |
| Recurring financial charges | 65 | €90,466 | €100,539 | +€10,074 | +11.1% |
| Profit (loss) for the period before taxes | 9903 | €2,150,747 | €1,730,003 | -€420,745 | -19.6% |
| Income taxes | 67/77 | €507,679 | €458,608 | -€49,071 | -9.7% |
| Profit (loss) for the period | 9904 | €1,643,069 | €1,271,395 | -€371,674 | -22.6% |
| Profit (loss) for the period to be appropriated | 9905 | €1,643,069 | €1,271,395 | -€371,674 | -22.6% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 7 October 2026 via checked.be.